Who invested in EVALUATE LIMITED?
One investor is on record as having backed EVALUATE LIMITED — Pharma commercial intelligence platform with forecasts and analytics, in B2B SaaS, United Kingdom. Each row below says whether the round came from the investor's own portfolio page or from the press.
evaluate.comEVALUATE LIMITED investors
No round dates are on record for EVALUATE LIMITED. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed EVALUATE LIMITED are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.